TOMMANNUUTTILIMINATIONUS009862693B2 (12 ) United States Patent ( 10 ) Patent No

TOMMANNUUTTILIMINATIONUS009862693B2 (12 ) United States Patent ( 10 ) Patent No

TOMMANNUUTTILIMINATIONUS009862693B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 , 862, 693 B2 Pietras et al. (45 ) Date of Patent : Jan . 9 , 2018 ( 54 ) COMPOUNDS AND METHODS OF ( 56 ) References Cited TREATING CANCER U . S . PATENT DOCUMENTS (71 ) Applicant : The Regents of the University of 4 , 574 ,123 A * 3 / 1986 Edwards . .. .. C07C 279/ 28 California , Oakland , CA (US ) 162 / 161 4 , 861, 760 A 8 / 1989 Mazuel et al. ( 72 ) Inventors : Richard J . Pietras , Los Angeles , CA 4 ,911 , 920 A 3 / 1990 Jani et al . (US ) ; Michael E . Jung, Los Angeles , 5 ,212 , 162 A 5 / 1993 Missel et al. CA (US ) ; Diana C . Marquez -Garban , 5 , 403 , 841 A 4 / 1995 Lang et al . 6 ,699 ,989 B1 * 3 / 2004 Shetty CO7D 215 / 56 Los Angeles, CA (US ) ; Gang Deng, 540 /474 Los Angeles, CA (US ) 7 , 285 ,681 B2 * 10 /2007 Moinet .. .. .. CO7D 295/ 215 564 /233 ( 73 ) Assignee : The Regents of the University of 7 ,671 , 019 B2 * 3 /2010 Tobia A61K 8 /44 California , Oaklnad , CA (US ) 514 / 1 . 1 8 , 853, 259 B2 10 /2014 Mylari Subject to any disclaimer, the term of this 2010 / 0087544 A1 4 / 2010 Kim et al. ( * ) Notice : 2011 /0196015 A1 8 / 2011 Kim et al . patent is extended or adjusted under 35 2011 / 0207810 Al 8 / 2011 Kim et al . U . S . C . 154 (b ) by 40 days. 2015 /0126518 Al 5 /2015 Kim et al . ( 21) Appl . No. : 14 /566 ,055 FOREIGN PATENT DOCUMENTS ( 22 ) Filed : Dec . 10 , 2014 WO WO - 96 /05309 A2 2 / 1996 WO WO - 96 /05309 A3 2 / 1996 (65 ) Prior Publication Data WO WO - 2011 /083998 A2 7 / 2011 WO WO - 2011 /083998 A3 7 / 2011 US 2015 /0158832 A1 Jun . 11, 2015 WO WO - 2011 / 147528 Al 12 / 2011 Related U . S . Application Data OTHER PUBLICATIONS (63 ) Continuation of application No . CAPLUS on STN , accession No . 2010 :923694 , Abstract of PCT/ US2013 /045250 , filed on Jun . 11, 2013 . CN101781273 Jul. 21 , 2010 . * Registry No . 793641 -52 - 8 , CAPLUS on STN , Dec . 7 , 2004. * (60 ) Provisional application No . 61/ 658 ,238 , filed on Jun . Alimova I . N . et al. (Mar . 15 , 2009) . “ Metformin inhibits breast 11 , 2012 . cancer cell growth , colony formation and induces cell cycle arrest in vitro , ” Cell Cycle 8 ( 6 ) : 909 - 915 . ( 51 ) Int. Cl. Berstein , L . M . ( Aug. 2010 ) . “ Modern approach to metabolic reha CO7D 295 /215 ( 2006 .01 ) bilitation of cancer patients : biguanides ( phenformin and CO7D 203 /20 ( 2006 .01 ) metformin ) and beyond ,” Future Oncol 6 ( 8 ) : 1313 - 23 . CO7D 211 / 16 ( 2006 . 01 ) Carey , L . A . et al . ( Jun . 7 , 2006 ). “ Race , breast cancer subtypes , and survival in the Carolina Breast Cancer Study ," JAMA 295 (21 ) : 2492 C07D 213 / 78 ( 2006 .01 ) 2502 . C07D 239 /28 ( 2006 . 01 ) Currie C . J . et al. ( Feb . 2012 , e - published Jan . 20 , 2012 ) . " Mortality C07D 401/ 12 ( 2006 . 01 ) after incident cancer in people with and without type 2 diabetes : A61K 31/ 155 ( 2006 . 01 ) impact of metformin on survival, ” Diabetes Care 35 ( 2 ): 299 - 304 . C07C 279 / 26 ( 2006 . 01 ) Dowling , R . J . et al . (Apr . 6 , 2011 ) . “ Understanding the benefit of metformin use in cancer treatment, ” BMC Med : 9 : 33 . A61K 31/ 4025 ( 2006 . 01 ) Dilman , V . M . et al . ( 1982 ) . “ Metabolic immunodepression and A61K 31 /445 ( 2006 .01 ) metabolic immunotherapy : an attempt of improvement in immuno A61K 31/ 4545 ( 2006 .01 ) logic response in breast cancer patients by correction of metabolic A61K 31/ 496 ( 2006 .01 ) disturbances , ” Oncology 39 ( 1 ) : 13 - 19 . A61K 31 /5377 ( 2006 .01 ) Evans , J . M . et al . (Jun . 4 , 2005 ) . " Metformin and reduced risk of cancer in diabetic patients , ” BMJ 330 ( 7503 ) :1304 - 1305 . C07C 279 / 22 ( 2006 .01 ) Foulkes, W . D . et al . (Nov . 11, 2010 ) . " Triple -negative breast can (52 ) U . S . CI. cer, " N Engl J Med . 363 ( 20 ) : 1938 - 1948 CPC . .. .. .. CO7D 295 /215 ( 2013 .01 ) ; A61K 31 / 155 International Search Report dated Nov . 1 , 2013 , for PCT Applica ( 2013 .01 ) ; A61K 31 /4025 ( 2013 .01 ) ; A61K tion No . PCT /US2013 /045250 , filed on Jun . 11 , 2013 , 4 pages . 31 /445 ( 2013 . 01 ) ; A61K 31/ 4545 ( 2013 .01 ) ; James , J. W . et al . (Sep . 1968 ) . “ The synthesis of some heterocyclic A61K 31/ 496 ( 2013 . 01 ) ; A61K 31 /5377 derivatives of biguanide with antibacterial activity , " J Med Chem (2013 . 01 ) ; C07C 279 / 22 ( 2013 . 01) ; C07C 11 ( 5 ): 942 - 945 . 279 / 26 ( 2013 .01 ) ; C07D 203 /20 ( 2013 . 01 ) ; (Continued ) CO7D 211/ 16 (2013 .01 ) ; C07D 213/ 78 Primary Examiner — Rebecca L Anderson ( 2013. 01 ) ; C07D 239 / 28 (2013 .01 ) ; C07D ( 74 ) Attorney , Agent, or Firm - Zachary L . Terranova ; 401 / 12 (2013 .01 ) Mintz , Levin , Cohn , Ferris , Glovsky and Popeo , P . C . ( 58 ) Field of Classification Search (57 ) ABSTRACT CPC .. .. CO7D 295 /215 ; C07D 203 / 20 ; CO7D Presented herein inter alia are novel compounds and meth 211710211 / 16 ; COLCO7D 213 / 78 ; CO7D 239 /28 ; CO7D 401/ 12 ods of using the same for the treatment of cancers . See application file for complete search history. 7 Claims, 10 Drawing Sheets US 9 , 862, 693 B2 Page 2 References Cited Kelarev, V . I . et al . (Sep . 1993 ) . “ Synthesis and properties of (56 ) derivatives of sym - triazines. 11 . Synthesis of 2 - amino - sym - triazines containing alkyl radicals , ” Chemistry of Heterocyclic Compounds OTHER PUBLICATIONS 29 ( 9 ) : 1087 - 1092 . Jiralerspong , S . et al. ( Jul. 10 , 2009 , e - published Jun . 1 , 2009 ) . Koh , M . et al. ( Apr. 2013 , e -published Feb . 22 , 2013 ) . “ A novel metformin derivative , HL010183 , inhibits proliferation and inva “ Metformin and pathologic complete responses to neoadjuvant sion of triple -negative breast cancer cells ,” Bioorg Med Chem chemotherapy in diabetic patients with breast cancer ,” J Clin Oncol. 21( 8 ) : 2305 - 2313 . 27 (20 ) :3297 -3302 . Liu , B . et al. ( Jul. 1 , 2009 , e -published Jul. 21, 2009 ) . " Metformin Jiralerspong, S . et al . ( Sep . 1 , 2009 ) . " Expanding the arsenal : induces unique biological and molecular responses in triple negative metformin for the treatment of triple -negative breast cancer ? ” Cell breast cancer cells , " Cell Cycle 8 ( 13 ) :2031 - 2040 . Cycle : 8 ( 17 ) : 2681 - 2684 . Nagasaka , H . et al . Yuki Gosei Kagaku Kyokaishi ( 1967 ) . Kihara , Y . et al. ( 1990 ) . Journal of Heterocyclic Chemistry 27 : 1213 25 ( 9 ) :802 -807 . (English translation of Abstract only ) . 1216 . Sahra , I. B . et al . (May 2010 , e - published May 4 , 2010 ) . “ Metformin Kelarev, V . I. et al . (May 1988 ). “ Synthesis and properties of in cancer therapy : a new perspective for an old antidiabetic drug ? ” sym - triazine derivatives . 7 . Synthesis of pyridyl - substituted Mol Cancer Ther 9 ( 5 ) : 1092 - 1099 . 2 -amino - and 2 , 4 -diamino - sym -triazines , ” Chemistry of Heterocy Taubes, G . ( Jan . 6 , 2012 ) . " Cancer research . Unraveling the obesity clic Compounds 24 ( 5 ) :550 - 555 . cancer connection ,” Science 335 (6064 ): 28 , 30 - 32 . Kelarev , V . I. et al. (Sep . 1992) . " Synthesis and properties of Written Opinion dated Nov. 1 , 2013 , for PCT Application No . sym - triazine derivatives 9 . Synthesis of 2 - amino - and 2 , 4 -diamino PCT/ US2013 /045250 , filed on Jun . 11, 2013 , 7 pages. sym - triazines containing furan fragments ,” Chemistry of Heterocy clic Compounds 28 ( 9 ) : 1060 - 1065 . * cited by examiner U . S . Patent Jan. 9 , 2018 Sheet 1 0f10 US 9 , 862 , 693 B2 FIC , 1 ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ?3 ?? ? ? . 282 ??????etw ? ?????? ? ? ? ? ? ? ? ?? ? ?? ? ? ? ? ? ? ? ? ? ? ? ? ???????????? 8944???????V9?????????} 8 ??????????????????? ????? ????3 %8385 ? ???i " " ? ; : ? ? ?? •••H•• ? ? ? ? ? ? , : 383 ; ????????????????????????????????????????????????????????????? ? 8_ 8A % ? ? 8_ ? ??? w & gt ; ? ? ?? ? ffx ?( ???????????????????????????????????????e 8_ ? { ACFT ???????????????????????????? e ????????????????????? cont _com = inopinion f { Y388 U . S . Patent Jan . 9 , 2018 Sheet 2 of 10 US 9, 862 , 693 B2 FIG . 2A MANNNNNNN N NNNNNNNN =-= - = - = -= - = =-= -= - ?????????????STYLE =-= - - - = ??????? whithinninnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnitinin ?? , “ ? ??????? ? ?? | FIG . 2B FYMVIT -AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMAHAMMMMMMMMMMMMMMMMMMMMMP MMMMMMMMMMMMMMMMMM www .www . www . riversinaimagaine .www .www wwwronmentNows… …… …… … …… … … … …… … Newmwww “ ? AirHANNAHAH ????????????????????? ManasoniaMainstationa IPH55974???????????????????AHAN ????????? ????? ??????, ? ????????????????????????? HANN U . S . Patent Jan . 9 , 2018 Sheet 3 of 10 US 9 , 862 ,693 B2 FIG . 2C * 3000 * 30002 w W10003 (QUODWuongelafjord 30004 NVNV. w jg005 * * * NENOVSMANN page ON WWWWWWWWWWWWWWWWWWWWWHCC1937 FIG . 2D theBE Pe V0002 waganiningi n isinesuivalenten imon 0005 (PQXudoX)dodelajoidja . n wwwwwwwwwwwwwwww HCC1806 wy 2 BV U . S . Patent Jan . 9 , 2018 Sheet 4 of 10 US 9 , 862 ,693 B2 FIG . 3A - - - - - - * * * * ** * * * * * X60 Segweiserovi - - ???????????????????????????????????????????m - lozo3xodisada - optoutoni se sitreba primeraintegrado * * * * * * * * * * * * * * * * * * * * A549 00 .. 1 FIG . 3B wwwwwww wwwww CelProliferation(control) trandapihtimentointer spretrgarnir eru potapetate * * * 0004 operas stranurecorded wwvini winniiiiiiiiiiiiiiiiiiiiiinnin MDAMB435 WWWWWWWWWWWWWWWWWWWWWWWWWW 110 . 5 U . S . Patent Jan . 9 , 2018 Sheet Sof 10 US 9, 862 , 693 B2 FIG. 44 … ?MAMAWAIWANNINAWAIWANNNNNNNNNNNNNNNNNNINeeweller trif; firsterferrary Ferrer Firsterferrary Ferrer , :: …: : : … … .… … :: … … * , … ** * * * *, * * , ? … “ ? ???? MAMAMAHANNERY ?3?????

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    61 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us